市場調査レポート
商品コード
1291352
シングルユースバイオリアクター市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Single-Use Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
シングルユースバイオリアクター市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 175 Pages
納期: 2~3営業日
|
世界のシングルユースバイオリアクターの市場規模は、2022年に29億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に15.3%の成長率(CAGR)を示し、2028年までに72億米ドルに達すると予測しています。
使い捨てバイオリアクターとして知られるシングルユースバイオリアクター(SUB)は、ステンレスやガラスを使った培養容器の代わりに、使い捨てのバッグに頼っています。柔軟性があり、使用や設置が簡単で、蒸気や水などのユーティリティ要件も少なくて済みます。さらに、人件費の削減、クロスコンタミネーションのリスクの最小化、洗浄工程やバリデーションの問題の排除など、さまざまなメリットがあります。その結果、世界中のCRO(医薬品開発業務受託機関)やCMO(医薬品製造業務受託機関)で幅広く使用されるようになりました。
SUBは、製薬業界で培地やバッファーの調製、細胞の採取、ろ過、精製、ウイルスの不活性化などに使用されています。また、創薬、バイオ燃料製造、ワクチンや抗体の開発など、学術・商業規模の研究所でも使用されています。このことは、急成長するバイオ医薬品産業と相まって、市場の成長を促す重要な要因の1つとなっています。さらに、従来のバイオリアクターのオートクレーブは、長くてコストがかかり、一貫性のない医薬品製造工程になりかねません。しかし、SUBは滅菌済みのバイオプロセスバッグを利用するため、滅菌のための追加コストと時間を削減することができます。また、従来のバイオリアクターに比べて可動部が少ないため、メンテナンスのコストも低く抑えることができます。さらに、SUBはステンレス製機器と比較して、環境に対する全体的な影響も小さくなります。このことは、世界中で臨床試験の数が増えていることと相まって、世界中でその需要を喚起しています。さらに、大手企業は顧客基盤を拡大し、地理的プレゼンスを高めるために、製品革新やM&Aにますます力を入れています。このことは、シングルユース技術(SUT)の採用の増加とともに、全体の売上と収益性を高めています。
Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million US$), 2017 & 2022
The global single-use bioreactors market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.
A single-use bioreactor (SUB), also known as a disposable bioreactor, relies on a disposable bag instead of a culture vessel made using stainless steel or glass. It is flexible and easy to use and install, and requires fewer utility requirements, including steam and water. Besides this, it reduces labor costs, minimizes the risk of cross-contamination, and eliminates the cleaning process and validation issue. As a result, it finds extensive applications in contract research organizations (CROs) and contract manufacturing organizations (CMOs) worldwide.
SUBs are employed in the pharmaceutical industry for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. They are also used in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and the development of vaccines and antibodies. This, in confluence with the burgeoning biopharmaceutical industry, represents one of the key factors impelling the growth of the market. Moreover, autoclaving a conventional bioreactor can become a lengthy, costly, and inconsistent pharmaceutical manufacturing process. However, SUBs utilize presterilized bioprocess bags and consequently reduce the additional costs and time of sterilization. Besides this, as they have fewer moving parts than conventional bioreactors, SUBs are less expensive to maintain. Apart from this, SUBs have a lower overall impact on the environment compared to stainless steel equipment. This, coupled with the growing number of clinical trials around the world, is catalyzing their demand across the globe. Furthermore, leading players are increasingly focusing on product innovations and mergers and acquisitions (M&A) to expand their customer base and increase their geographical presence. This, along with the rising adoption of single-use technology (SUT), is augmenting the overall sales and profitability.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioreactors market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type, cell type, molecule type and end user.
Single-use Bioreactor Systems
Media Bags
Filtration Assemblies
Others
Stirred-tank Bioreactors
Wave-induced Bioreactors
Bubble-column Bioreactors
Others
Mammalian Cell
Bacteria
Yeast
Others
Vaccines
Monoclonal Antibodies
Stem Cells
Recombinant Proteins
Others
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Academic and Research Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single-use bioreactors market in 2022?
2. What is the expected growth rate of the global single-use bioreactors market during 2023-2028?
3. What are the key factors driving the global single-use bioreactors market?
4. What has been the impact of COVID-19 on the global single-use bioreactors market?
5. What is the breakup of the global single-use bioreactors market based on the product type?
6. What is the breakup of the global single-use bioreactors market based on the type?
7. What is the breakup of the global single-use bioreactors market based on the cell type?
8. What is the breakup of the global single-use bioreactors market based on the molecule type?
9. What are the key regions in the global single-use bioreactors market?
10. Who are the key players/companies in the global single-use bioreactors market?